Weight-Loss drug may cut heart flutter after ablation in overweight patients

This study looks at whether tirzepatide, a drug used for weight loss, can help overweight or obese people with a type of irregular heartbeat called atrial fibrillation (AFib). About 200 adults will receive either tirzepatide injections plus standard care, or standard care alone, starting before and continuing after a heart procedure called catheter ablation. The main goal is to see if the drug reduces the amount of time the heart is in AFib and helps with weight loss over a year.